Trevor M. Feinstein, MD, Examines Docetaxel With or Without Plinabulin in Stage IIIB/IV EGFR Wild-Type NSCLC - Cancer Network

Trevor M. Feinstein, MD, discussed the phase 3 DUBLIN-3 trial evaluating docetaxel with or without plinabulin for patients with EGFR wild-type stage IIIB/IV non–small cell lung cancer.

The phase 3 DUBLIN-3 trial (NCT02504489) aimed to determine if use of docetaxel with plinabulin could improve efficacy and safety outcomes vs docetaxel alone for patients with EGFR wild-type stage II… [+5185 chars]

full article...